Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer
Signal Transduction and Targeted Therapy - Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer
Signal Transduction and Targeted Therapy - Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer